These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
890 related articles for article (PubMed ID: 21102366)
1. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion. Sonoda Y; Arimura N; Shimura M; Sakamoto T Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
3. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Lim JW; Lee HK; Shin MC Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA Retina; 2007; 27(9):1187-95. PubMed ID: 18046223 [TBL] [Abstract][Full Text] [Related]
5. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114 [TBL] [Abstract][Full Text] [Related]
6. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract. Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251 [TBL] [Abstract][Full Text] [Related]
7. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection. Kim MW; Moon H; Yang SJ; Joe SG Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema. Sonoda S; Sakamoto T; Yamashita T; Otsuka H; Shirasawa M; Kakiuchi N; Uchino E; Terasaki H; Kawano H Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3979-85. PubMed ID: 24906857 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Cheng KC; Wu WC; Chen KJ Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117 [TBL] [Abstract][Full Text] [Related]
10. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456 [TBL] [Abstract][Full Text] [Related]
11. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585 [TBL] [Abstract][Full Text] [Related]
13. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema. Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332 [TBL] [Abstract][Full Text] [Related]
15. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study. Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema. Tsilimbaris MK; Pandeleondidis V; Panagiototglou T; Arvanitaki V; Fragiskou S; Eleftheriadou M; Tsika C; Papadaki T Semin Ophthalmol; 2009; 24(6):225-30. PubMed ID: 19954371 [TBL] [Abstract][Full Text] [Related]
17. Initial macular thickness and response to treatment in diabetic macular edema. Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
19. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion]. Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]